Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 1999
Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse
M S Tallman, D Hakimian, K J Kopecky, et al.
Blood
|
September 26, 2000
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience
M S Tallman, D Neuberg, J M Bennett, et al.
Blood
|
November 1, 1993
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques
A A Ross, B W Cooper, H M Lazarus, et al.
Free Radical Biology & Medicine
|
March 1, 1995
Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity
L I Gordon, S G Brown, M S Tallman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 1999
Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490)
C L Bennett, T J Stinson, M S Tallman, et al.
Leukemia
|
September 10, 2004
Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)
P H Wiernik, E Paietta, O Goloubeva, et al.
Blood
|
December 23, 1999
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome
M S Tallman, J W Andersen, C A Schiffer, et al.
Bone Marrow Transplantation
|
June 6, 2006
Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?
J Mehta, L I Gordon, M S Tallman, et al.
Bone Marrow Transplantation
|
January 31, 2006
Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation
S Singhal, L I Gordon, M S Tallman, et al.
The New England Journal of Medicine
|
October 9, 1997
All-trans-retinoic acid in acute promyelocytic leukemia
M S Tallman, J W Andersen, C A Schiffer, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 1999
Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse
M S Tallman, D Hakimian, K J Kopecky, et al.
Blood
|
September 26, 2000
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience
M S Tallman, D Neuberg, J M Bennett, et al.
Blood
|
November 1, 1993
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques
A A Ross, B W Cooper, H M Lazarus, et al.
Free Radical Biology & Medicine
|
March 1, 1995
Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity
L I Gordon, S G Brown, M S Tallman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 1999
Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490)
C L Bennett, T J Stinson, M S Tallman, et al.
Leukemia
|
September 10, 2004
Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)
P H Wiernik, E Paietta, O Goloubeva, et al.
Blood
|
December 23, 1999
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome
M S Tallman, J W Andersen, C A Schiffer, et al.
Bone Marrow Transplantation
|
June 6, 2006
Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?
J Mehta, L I Gordon, M S Tallman, et al.
Bone Marrow Transplantation
|
January 31, 2006
Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation
S Singhal, L I Gordon, M S Tallman, et al.
The New England Journal of Medicine
|
October 9, 1997
All-trans-retinoic acid in acute promyelocytic leukemia
M S Tallman, J W Andersen, C A Schiffer, et al.
Page
of 10